PSORIASIS
Clinical trials for PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS trials appear
Sign up with your email to follow new studies for PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early skin disease drug trial halted
Disease control TerminatedThis early-stage study aimed to test the safety and side effects of a new drug called XmAb27564 in people with plaque psoriasis and atopic dermatitis (eczema). Participants received four injections of either the drug or a placebo over several weeks. The study was terminated early…
Matched conditions: PSORIASIS
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could a cheap old drug make expensive psoriasis treatments work better and last longer?
Disease control TerminatedThis study tested whether adding a low dose of an older, inexpensive drug called methotrexate could help people with moderate-to-severe psoriasis get better results from newer, more expensive anti-TNF biologic drugs. The goal was to see if the combination helped patients maintain…
Matched conditions: PSORIASIS
Phase: PHASE4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists probe surprising link between skin patches and blood sugar
Knowledge-focused TerminatedThis small, terminated study aimed to understand the connection between psoriasis and diabetes. Researchers took small skin samples from 10 people with plaque psoriasis to check how insulin acts in their skin patches. The goal was to see if this could explain why people with psor…
Matched conditions: PSORIASIS
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC